G. Durst

发表

Characteristic physical properties and structural fragments of marketed oral drugs.

Ian A. Watson, M. Vieth, R. Higgs, 2004, Journal of medicinal chemistry.

Particle swarm optimization and neural network application for QSAR

Zhiwei Wang, Russell C. Eberhart, Zina Ben-Miled, 2004, 18th International Parallel and Distributed Processing Symposium, 2004. Proceedings..

Identification of potent and selective retinoic acid receptor gamma (RARγ) antagonists for the treatment of osteoarthritis pain using structure based drug design.

G. Durst, T. I. Richardson, T. Page, 2016, Bioorganic & medicinal chemistry letters.

Styrene monomer migration as monitored by purge and trap gas chromatography and sensory analysis for polystyrene containers

G. Durst, Edward A. Laperle, G. L. Durst, 1990 .

Benzopyrans are selective estrogen receptor beta agonists with novel activity in models of benign prostatic hyperplasia.

G. Durst, A. Boodhoo, T. I. Richardson, 2006, Journal of medicinal chemistry.

Inhibition of photosystem II electron transport and structure-activity relationships among herbicidally active 3-butenanilides

G. Durst, J. Webster, V. J. Streusand, 1992 .

Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 3: synthesis of cyclopentanone and cyclohexanone intermediates for C-ring modification.

G. Durst, T. I. Richardson, J. Shah, 2007, Bioorganic & medicinal chemistry letters.

Design and synthesis of a novel series of [1-(4-hydroxy-benzyl)-1H-indol-5-yloxy]-acetic acid compounds as potent, selective, thyroid hormone receptor β agonists.

G. Durst, C. Montrose‐Rafizadeh, L. Stramm, 2015, Bioorganic & medicinal chemistry letters.

Natural products as insecticides: the biology, biochemistry and quantitative structure-activity relationships of spinosyns and spinosoids.

G. Durst, T. Sparks, G. D. Crouse, 2001, Pest management science.

Acyl sulfonamide anti-proliferatives: benzene substituent structure-activity relationships for a novel class of antitumor agents.

G. Durst, P. Hipskind, B. Teicher, 2004, Journal of medicinal chemistry.

Molecular mechanics (MM2) calculations and cone angles of phosphine ligands

G. Durst, P. L. Bock, J. A. Mosbo, 1994 .

Defining Target Engagement Required for Efficacy In Vivo at the Retinoic Acid Receptor-Related Orphan Receptor C2 (RORγt).

G. Durst, D. Clawson, R. Morphy, 2021, Journal of medicinal chemistry.

The Identification and Optimization of Oömycete Dihydroorotate Dehydrogenase Inhibitors as Fungicides

G. Durst, M. Henry, M. H. Parker, 2001 .

Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 4: functionalization of the benzopyran A-ring.

Sean R. Dinn, G. Durst, J. Dodge, 2007, Bioorganic & medicinal chemistry letters.

Comparative Molecular Field Analysis (CoMFA) of Herbicidal Protoporphyrinogen Oxidase Inhibitors using Standard Steric and Electrostatic Fields and an Alternative LUMO Field

G. Durst, 1998 .

Structural features underlying raloxifene's biophysical interaction with bone matrix.

M. J. Chalmers, G. Durst, D. Burr, 2016, Bioorganic & medicinal chemistry.